EyePoint Pharmaceuticals (United Kingdom)
DURAVYU™ offers a multi-mechanism of action for the treatment of serious retinal diseases. DURAVYU™ combines vorolanib, a differentiated and patent protected, tyrosine kinase inhibitor (TKI) formulated in proprietary, next-generation bio-erodible Durasert E™ for sustained intraocular delivery. Were trying to help improve the lives of patients with serious retinal diseases.
Basic Information
- Category: business
- Website: https://eyepointpharma.com/
Evidence and Sources
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about EyePoint Pharmaceuticals (United Kingdom).
- Canonical profile: https://brandsource.ai/brands/eyepoint-pharmaceuticals-united-kingdom
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/eyepoint-pharmaceuticals-united-kingdom/json-ld
- Citation profile API: https://brandsource.ai/api/brands/eyepoint-pharmaceuticals-united-kingdom/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (74/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
DURAVYU™ offers a multi-mechanism of action for the treatment of serious retinal diseases. DURAVYU™ combines vorolanib, a differentiated and patent protected, tyrosine kinase inhibitor (TKI) formulated in proprietary, next-generation bio-erodible Durasert E™ for sustained intraocular delivery. Were trying to help improve the lives of patients with serious retinal diseases.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.